» Articles » PMID: 6744204

Patterns of Bone Marrow Involvement in Chronic Lymphocytic Leukemia and Small Lymphocytic (well Differentiated) Non-Hodgkin's Lymphoma. Its Clinical Significance in Relation to Their Differential Diagnosis and Prognosis

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 1984 Aug 15
PMID 6744204
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Forty-eight patients with chronic lymphocytic leukemia (CLL), and 12 patients with small (well differentiated) lymphocytic lymphoma (WDL) were histologically evaluated for their pattern of bone marrow (BM) involvement. Four different types of BM infiltration were recognized: nodular (N), interstitial (I), nodular and interstitial (mixed) and diffuse (D). The pattern of BM involvement was compared with the clinical, laboratory, and survival status in all patients. The extent of the disease in CLL patients, was determined by the Rai and the International Workshop on CLL Staging Systems, while in WDL patients the Ann Arbor staging system was used. In the CLL group the N pattern was found in 8%, the I in 33%, the mixed in 31%, and the D in 27% of the patients. Based on the International Workshop on CLL Staging System, the I pattern of BM involvement was more frequently found in Stage A (56%), the mixed in Stage B (68%), and the D in Stage C disease (90%). All CLL patients with D pattern required treatment from the beginning, contrary to CLL patients with the other patterns, in whom therapy was required in less than 50%. Similarly, deaths were more common in the D pattern in whom therapy pattern than in the other patterns. In the WDL patients BM involvement was found in 4 of 12, (33%) and its pattern of positivity was always nodular, although most patients (10 of 12) had advanced disease. It is concluded that the frequency of BM involvement may contribute in the differential diagnosis of WDL from CLL. In addition, the pattern of BM infiltration correlates very well with the International Staging System for CLL, and the pattern of BM positivity in CLL patients also has prognostic significance.

Citing Articles

Bone Marrow Lymphoid Niche Adaptation to Mature B Cell Neoplasms.

Dumontet E, Mancini S, Tarte K Front Immunol. 2021; 12:784691.

PMID: 34956214 PMC: 8694563. DOI: 10.3389/fimmu.2021.784691.


The Role of CD44 in the Pathophysiology of Chronic Lymphocytic Leukemia.

Gutjahr J, Greil R, Hartmann T Front Immunol. 2015; 6:177.

PMID: 25941526 PMC: 4403525. DOI: 10.3389/fimmu.2015.00177.


Appearance and Disappearance of Chronic Myeloid Leukemia (CML) in Patient with Chronic Lymphocytic Leukemia (CLL).

Payandeh M, Sadeghi E, Khodarahmi R, Sadeghi M Int J Hematol Oncol Stem Cell Res. 2015; 8(4):49-53.

PMID: 25774268 PMC: 4345298.


Structure and function of the hematopoietic cancer niche: focus on chronic lymphocytic leukemia.

Fecteau J, Kipps T Front Biosci (Schol Ed). 2011; 4(1):61-73.

PMID: 22202043 PMC: 4114230. DOI: 10.2741/s251.


Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells.

Balakrishnan K, Burger J, Quiroga M, Henneberg M, Ayres M, Wierda W Blood. 2010; 116(7):1083-91.

PMID: 20442367 PMC: 2938131. DOI: 10.1182/blood-2009-10-246199.